Showing results (11-20 of 73) with videos related to
Sort By:
Pageof 8
Health Communication|October 1, 2015
Heteronormativity and practitioner-patient interactionPooja Dushyant Utamsingh, Laura Smart Richman, Julie L Martin, et al.Health Affairs Scholar|February 24, 2026
Impact of US government funding freezes on the HIV response: findings from a rapid survey in 32 countriesEllen Brazier, Stephany N Duda, Jeremy Ross, et al.Palliative Medicine|October 1, 2019
Predicting survival in patients with advanced cancer in the last weeks of life: How accurate are prognostic models compared to clinicians' estimates?David Hui, Jeremy Ross, Minjeong Park, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 15, 2022
Brief Report: Mortality After Loss to Follow-Up-A Linkage Study of People Living With HIV in Thailand and MalaysiaAwachana Jiamsakul, Yasmin Gani, Anchalee Avihingsanon, et al.Plos One|September 9, 2021
Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysisDavid C Boettiger, Pairoj Chattranukulchai, Anchalee Avihingsanon, et al.The American Journal of Pathology|July 18, 2009
Oxidized phospholipid species promote in vivo differential cx43 phosphorylation and vascular smooth muscle cell proliferationScott R Johnstone, Jeremy Ross, Michael J Rizzo, et al.The Journal of Antimicrobial Chemotherapy|February 28, 2024
Changes in atherosclerotic cardiovascular disease risk over time among people living with HIVWeisi Chen, Kathy Petoumenos, Agus Somia, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2022
Recent Trends in Adult and Pediatric Antiretroviral Therapy Monitoring and FailureDavid C Boettiger, Vu Thien An, Nagalingeswaran Kumarasamy, et al.Journal of Virus Eradication|December 6, 2018
Mental health and HIV: research priorities related to the implementation and scale up of 'treat all' in sub-Saharan AfricaAngela M Parcesepe, Charlotte Bernard, Robert Agler, et al.BMJ Open|August 22, 2024
HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST)Matthias Egger, Mamatha Sauermann, Tom Loosli, et al.Pageof 8